Диссертация (1174263), страница 21
Текст из файла (страница 21)
– 2015; - Vol. 12. – P. 114.113. Corrigan F. Neurogenic inflammation after traumatic brain injury and itspotentiation of classical inflammation [Text] / F. Corrigan, K.A. Mander, A.V.Leonard, [et al.] // J Neuroinflammation. – 2016. – Vol. 11, N. 13. - P. 264.141114. AtanganaE.IntravascularActivated Microglia andInflammationContributestoTriggersSecondaryIntracerebralBrainInjury AfterExperimental Subarachnoid Hemorrhage (eSAH) [Text] / E.
Atangana, U.C.Schneider, K. Blecharz, [et al.] // Transl Stroke Res. - 2016; Vol. 1.115. Sun Y.M. The effects of deferoxamine on inhibition for microglia activation andprotection of secondary nerve injury after intracerebral hemorrhage in rats [Text] /Y.M. Sun, Y.T. Wang, L. Jiang, [et al.] // Pak J Pharm Sci. – 2016. – Vol. 29. – P.1087 – 93.116. ShiH.Sinomenineenhances microglia M2polarizationandattenuatesinflammatory injury in intracerebral hemorrhage [Text] / H. Shi, K. Zheng, Z. Su,[et al.] // J Neuroimmunol. – 2016.
- Vol. 299, N. 15. – P. 28 – 34.117. Marik PE. Fever in the ICU [Text] / P.E. Marik // Chest. – 2000. – Vol. 117, N. 3.– P. 855 – 869.118. Fernandez A. Fever after subarachnoid hemorrhage: Risk factors impact onoutcome [Text] / A. Fernandez, J.M. Schmidt, J.
Claassen, [et al.] // Neurology. –2007. – Vol. 68. – P. 1013 – 1019.119. Commichau C, Scarmeas N, Mayer SA. Risk factors for fever in the neurologicintensive care unit [Text] / C. Commichau, N. Scarmeas, S.A. Mayer // Neurology.– 2003. – Vol. 60. – P. 837 – 841.120. Diringer M.N. Elevated body temperature independently contributes to increasedlength of stay in neurologic intensive care unit patients [Text] / M.N. Diringer, N.L.Reaven, S.E. Funk [et al.] // Crit Care Med – 2004 – Vol. 32. – P. 1489–1495.142121. Kilpatrick M.M.
Hyperthermia in the neurosurgical intensive care unit [Text] /M.M. Kilpatrick, D.W. Lowry, A.D. Firlik, [et al]. Neurosurgery. – 2000. – Vol.47,4. – P. 850–5.122. Savage K.E, Neurogenic Fever after Acute Traumatic Spinal Cord Injury: AQualitative Systematic Review [Text] / C.V. Oleson, G.D. Schroeder, [et al.] //Global Spine J. - 2016.
- Vol.6. - N.6. - P.607-14.123. Ulger F. Fatal fever of unknown origin in acute cervical spinal cord injury: fivecases [Text] / F. Ulger, A. Dilek, D. Karakaya [et al.] // J Spinal Cord Med. – 2009.-Vol.32. – N.3. – P.343-8.124. Kumar A.D. Leukocytosis in patients with neurologic deterioration after acuteischemic stroke is associated with poor outcomes [Text] / A.D.
Kumar, A.K.Boehme, J.E. Siegler, [et al.] // J Stroke Cerebrovasc Dis. – 2013. – Vol.22. – 7. –P.111-117.125. Sun W. Correlation of leukocytosis with early neurological deterioration followingsupratentorial intracerebral hemorrhage [Text] / W. Sun, A. Peacock, J. Becker, etal. //J Clin Neurosci.
– 2012. -Vol.19. – N.8. - P. 1096-1100.126. Tillet W. S. Serological reactions in pneumonia with a non-protein somatic fractionof pneumococcus [Text] / W. S. Tillet, T. Jr. Francis // J. Exp. Med. - 2010. - Vol.52. - Р. 561-571.127. Baumann H. The acute phase response [Text] / H. Baumann, J. Gauldie //Immunologie Today. - 2004. – N.2. - Р 74-80.128. Verma S. C-Reactive Protein Structure Affects Function [Text] / S.Verma, P.E.Szmitko, E.T.H. Yeh // Circulation. – 2004. – Vol.109.
– P.1914 –1917.143129. Shrive A.K. Three dimensional structure of human Creactive protein [Text] / A.K.Shrive, G.M.T. Cheetham, D. Holden, [et al.] // Nat. Struct. Biol. – 1996. Vol.3.– P.346–354.130. Vincent J.L. Biomarkers in the critically ill patient: C-reactive protein [Text] / J.L.Vincent, K. Donadello, X. Schmit // Crit Care Clin. – 2011. – Vol.27. – P.241-51.131. Beygi S. C-reactive protein in psoriasis: a review of the literature [Text] / S. Beygi,V. Lajevardi, R. Abedini //J Eur Acad Dermatol Venereol 2014. – Vol.28.
– N.6.– P.700-11.132. Al-Jabi Y. Value of C-reactive protein after neurosurgery: a prospective study[Text] / Y. Al-Jabi, A. El-Shawarby // Br J Neurosurg. - 2010. – Vol.24. – N.6. P.653–659.133. Mirzayan M. Response of C-reactive protein after craniotomy for microsurgery ofintracranial tumors [Text] / M. Mirzayan, A. Gharabaghi, M. Samii, [et al.]//Neurosurgery. - 2007. – Vol. 60. – N.4. – P.621– 625.134. Mok J. Use of C-reactive protein after spinal surgery: comparison with erythrocytesedimentation rate as predictor of early postoperative infectious complications[Text] / J. Mok, M. Pekmezci, S.L.
Piper, [et al.] //Spine. – 2008. – Vol.33. – N.4.– P.415–421.135. Mierzchala M. Quantitative indices of dynamics in concentrations oflipopolysaccharide-binding protein (LBP) as prognostic factors in severesepsis/septic shock patients–comparison with CRP and procalcitonin [Text] / M.Mierzchala, M. Krzystek-Korpacka, A. Gamian, [et al.] // Clin Biochem. – 2011. –Vol.44. – N.5-6. – P.357–363.144136. Oconnor E. Serum procalcitonin and C-reactive protein as markers of sepsis andoutcome in patients with neurotrauma and subarachnoid haemorrhage [Text]/ E.Oconnor, B.
Venkatesh, C. Mashongonyika, [et al.] // Anaesth Intensive Care. –2004. – Vol. 32. - P. 465–70.137. Schuetz P. Biomarkers to improve diagnostic and prognostic accuracy in systemicinfections [Text] / P. Schuetz, M. Christ-Crain, B. Müller // Curr. Opin. Crit. Care.– 2007. – Vol.13. - N.5.
– P.578–585.138. Becker K.L. Procalcitonin assay in systemic inflammation, infection, and sepsis:clinical utility and limitations [Text] / K.L. Becker, R. Snider, E. Nylen // Crit. CareMed. - 2008. Vol.36. – N.3. P.941–995.139. Charles P.E. Serum procalcitonin elevation in critically ill patients at the onset ofbacteremia caused by either Gram negative or Gram-positive bacteria [Text] / P.E.Charles, S. Ladoire, S.
Aho [et al.]// BMC Infect. Dis. - 2008. – Vol.8. - N.38. –P.2334–2338.140. Jemli B. Procalcitonin in invasive candidosis [Text] / B. Jemli, Z. Aouni, I. Lebben[et al.]// Ann. Biol. Clin. – 2007. – Vol.65. – N.2. – P.169–173.141. Reinhart K. Biomarkers in the critically ill patient: procalcitonin [Text] / K.Reinhart, M. Meisner// Crit Care Clin. - 2011. – N.27. - P. 253-63.142. Suprin E. Procalcitonin: a valuable indicator of infection in a medical ICU? [Text]/ E.
Suprin, C. Camus, A. Gacouin, [et al.] // Intensive Care Med. – 2000. – Vol.26.P. 1232–8.143. Martinez R. Serum procalcitonin monitoring for differential diagnosis ofventriculitis in adult intensive care patients [Text] / R. Martinez, C. Gaul, M.Buchfelder, [et al.]// Intensive Care Med. – 2002. – N.28. – P.208–210.145144. Meisner M. Update on Procalcitonin Measurements [Text] / M. Meisner //Ann LabMed. – 2014. -Vol.34. – 4.
– P.263-273.145. Sridharan P. The efficacy of procalcitonin as a biomarker in the management ofsepsis: slaying dragons or tilting at windmills? [Text] / P. Sridharan, R.S.Chamberlain // Surg Infect. - 2013. – Vol.14.- N.6. – P.489-511.146. Shozushima T. Usefulness of presepsin (sCD14-ST) measurements as a marker forthe diagnosis and severity of sepsis that satisfied diagnostic criteria of systemicinflammatory response syndrome [Text] / T.
Shozushima, G. Takahashi, N.Matsumoto, [et al.] // J Infect Chemother. – 2011. - Vol. 17. – P. 764–769.147. Spanuth E. Utility of PATHFAST Presepsin in Septic Patients Admitted to theEmergency Room / E. Spanuth, J. Wilhelm, H. Loppnow, [et al.]// 1st Central andEastern European Sepsis Forum SepsEast Budapest, September 19-23,2012.148. Ulla M. Diagnostic and prognostic value of Presepsin in the management of sepsisin the emergency department: a multicentre prospective study [Text] / M. Ulla, E.Pizzolato, M. Lucchiari [et al.]// Crit Care. – 2013. – Vol.17.
– N.4. – P.168.149. Cebreiros-Lopez I. Correlation od Presepsin (SCD14-ST) with PCT in critically illpatients: Diagnostics usefulness in Sepsis / I. Cebreiros-Lopez, J.A. NogueraVelasco, A. Martinez-Ruiz [et al.] // Euro Med Lab. – 2013. – poster M097.150. Ross D. Differentiation of aseptic and bacterial meningitis in postoperativeneurosurgical patients [Text] / D. Ross, H.
Rosegay, V. Pons // J. Neurosurg. -1988.– Vol. 69. – P. 669 – 674.151. Nwachuku E.L. Time course of cerebrospinal fluid inflammatory biomarkers andrelationship to 6-month neurologic outcome in adult severe traumatic brain injury146[Text] / E.L. Nwachuku, A.M. Puccio, A. Adeboye, [et al.] //. Clin NeurolNeurosurg. – 2016. – Vol. 149. – P. 1 – 5.152. Conen A. Characteristics and treatment outcome of cerebrospinal fluid shuntassociated infections in adults: a retrospective analysis over an 11-year period[Text] / A. Conen, L.N. Walti, A.
Merlo [et al.] // Clin Infect Dis – 2008. – Vol. 47– P. 73–82.153. Lyke K.E. Ventriculitis complicating use of intraventricular catheters in adultneurosurgical patients [Text] / K.E. Lyke, O.O. Obasanjo, M.A. Williams, [et al.]// Clin Infect Dis. – 2001. – Vol.33. – P. 2028 – 2033.154. McClelland S 3rd. Postoperative central nervous system infection: incidence andassociated factors in 2111 neurosurgical procedures. [Text] / S. McClelland 3rd,W.A. Hall // Clin Infect Dis. – 2007. – Vol. 45. – 55 – 9.155. Leib S. Predictive value of cerebrospinal fluid (CSF) lactate levels versusCSF/blood glucose ratio for the diagnosis of bacterial meningitis followingneurosurgery [Text] / S.
Leib, R. Boscacci, O. Gratzl, [et al.] // Clinical InfectionsDiseases. – 1999. – Vol. 29. – P. 69 – 74.156. Seehusen D.A. Cerebrospinal fluid analysis [Text] / D.A. Seehusen, M.M. Reeves,D.A. Fomin. // Am Fam Phys. – 2003. – Vol. 68. – P. 1103 – 8.157. Komorowski R.A. Comparison of cerebrospinal fluid C-reactive protein and lactatefor diagnosis of meningitis [Text] / R.A. Komorowski, S.G. Farmer, K.K. Knoxx,[et al.] // Journal of Clinical Microbiology.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
